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Flow cytometric evaluation of T and B 
lymphocyte percentage  
in chronic kidney disease
ABSTRACT
Introduction. T and B lymphocytes play crucial roles in adaptive immunity. These cells are negatively affected 
in multiple disorders, including chronic kidney disease. The purpose of this study was to compare T and 
B lymphocyte ratios between patients with chronic kidney disease and healthy controls. 
Methods. In this study, we evaluated the percentages of patient and donor (healthy control) lymphocytes 
referred to our laboratory between 2012 and 2014. In total 103 patient-donor couples were tested by the 
FCXM method. CD3-PerCP and CD19-PE monoclonal antibodies were used in order to differentiate T and 
B cells, respectively. T and B cell percentages of the participants were statistically compared.
Results. The mean age of the investigated patients and donors was 36.3 ± 13.7 and 46.2 ± 12.4 years, 
respectively. Of the studied patients, 45.6% and 54.3% were female and male, whereas 54.3% and 45.6% 
of donors were female and male, respectively. In the investigated group, 42 patients were preemptive, 
45 subjects were treated with haemodialysis, and 16 individuals were on peritoneal dialysis. T and B 
lymphocyte percentages in the healthy group were higher than in patients with chronic kidney disease. 
However, the difference reached statistical significance only for T lymphocytes (p < 0.05). The percentages 
of total lymphocytes, and T and B lymphocytes in patients treated with haemodialysis were numerically 
lower than in those on peritoneal dialysis. In addition, we found that patients with chronic kidney disease 
had lower concentrations of haemoglobin and albumin than healthy controls.
Conclusion. This study suggests that patients with advanced chronic kidney disease have lower rates of 
lymphocytes that healthy controls. This fact may at least partially explain impaired immunity in this setting. How-
ever, our findings require confirmation and detailed investigation of underlying mechanisms in further studies.
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Introduction
Chronic kidney disease (CKD) has a high worldwide 
prevalence and incidence. More than two million CKD 
patients worldwide survive due to dialysis treatment or 
renal transplant [1]. In Turkey, more than 62,000 people 
suffer from CKD, requiring long-term dialysis. Of these 
patients, approximately 8% are transplanted from de-
ceased donors or living, related donors [2]. Although the 
death rates due to bacterial infection have decreased in 
the general population, it is the second most prevalent 
cause of death in the CKD population. This may be 
caused by CKD-related impaired immune response. Ob-
served immunological abnormalities in CKD patients in-
clude: diminished antibody synthesis in B lymphocytes, 
defective T lymphocyte-mediated immunity, failure in 
antigen presentation by monocytes/macrophages, and 
decreased phagocytic functions of granulocytes and 
monocytes/macrophages. The mechanisms responsi-
ble for these abnormalities have not been completely 
understood [3].
In this study, we aimed to compare lymphocyte 
percentages between CKD patients and healthy indi-
viduals. Our additional goals were to investigate the 
relationship between dialysis type, duration, and the 
lymphocyte percentage and to assess concentrations 
of haemoglobin and albumin, and the percentages of 
lymphocyte, in the compared groups.
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Table 1. The comparison of investigated parameters between the study and control groups
Group Age  
(years)
Total 
lymphocytes 
(%)
T 
lymphocytes 
(%)
B 
lymphocytes 
(%)
Haemoglobin  
[g/dL]
Albumin  
[g/dL]
Dialysis
duration 
(months)
Patients
(n = 103)
36.3 ± 13.7 48.9 ± 15.6 61.3 ± 22.0 1.6 ± 1.3 11.6 ± 1.7 4.1 ± 0.5 15.4 ± 31.6
Controls
(n = 103)
46.2 ± 12.4 54.7 ± 13.8 72.0 ± 14.1 2.5 ± 1.7 13.6 ± 1.8 4.4 ± 0.5 n/a
p-value ns ns < 0.05 ns ns ns n/a
n/a — not applicable; ns — non-significant
Methods
In this study, a total of 103 CKD patients and their 
103 donors (healthy controls) referred to our laboratory 
between 2012 and 2014 were included. In our laborato-
ry, flow cytometry cross match (FCXM) is a routine test 
for pre-transplant assessment. T and B lymphocytes of 
this cohort were analysed by flow cytometry. The overall 
study cohort was further divided into three subgroups 
according to their dialysis status.
Donor and patient lymphocytes were used in or-
der to evaluate crossmatch and autologous results, 
respectively. We assessed total, T, and B lymphocyte 
percentages during FCXM. Anti-human CD-3 PerCP 
(Becton Dickenson, Sen Jose, USA) monoclonal anti-
body was used for the identification of T lymphocytes, 
while anti-human CD-19 PE (Becton Dickenson, San 
Jose, USA) monoclonal antibody was used for B lym-
phocytes. Lymphocytes were selected on the basis of 
their forward and side scatter characteristics by flow 
cytometry. Fluorescence intensity was measured with 
the FACS Calibur (Becton Dickenson, USA) flow cytom-
eter using Cell Quest Pro software. 
This study was performed in accordance with the 
ethical standards of the responsible committee on hu-
man experimentation and with the Helsinki Declaration 
of 1975, as revised in 2000. Written, informed consent 
was obtained from all study participants. 
Descriptive and frequency analyses were performed 
using IBM SPSS version 21.0 for Windows (SPSS, Chi-
cago, Ill, United States). Chi-square and Fisher’s exact 
tests were used to compare median and percentage 
ratios between groups. Haemoglobin and albumin 
levels of the patient’s ratios between the groups were 
compared by Student’s t test. In a one-way Anova, 
multiple mean values were compared by Tukey’s 
multiple comparison tests. p < 0.05 was accepted as 
statistically significant.
Results
The mean age of the 103 CKD patients and donors 
was 36.3 ± 13.7 and 46.2 ± 12.4 years, respectively. 
Importantly, none of the patients or controls presented 
with symptoms of an active infection during the study. Of 
the studied patients, 45.6% and 54.3% were female and 
male, whereas 54.3% and 45.6% of donors were female 
and male, respectively. Dialysis duration, demographic 
characteristics, and flow cytometry results of the study 
participants (mean ± SD) are shown in Table 1.
We found that all assessed parameters were nu-
merically higher in the control group than in the overall 
study group (Tab. 1 and Fig. 1). However, the difference 
reached statistical significance only for T lymphocytes 
(p < 0.05). 
In the investigated group, 42 patients were preemp-
tive, 45 subjects were treated with haemodialysis, and 
16 individuals were on peritoneal dialysis. Values of 
investigated parameters (percentage of lymphocytes, 
concentrations of haemoglobin and albumin) in the 
three study subgroups and in the control group are 
displayed in Table 2.
The percentages of total lymphocytes, and T and 
B lymphocytes in patients treated with haemodialysis 
were numerically lower than in those on peritoneal 
dialysis. However, the differences were not statistically 
significant (p > 0.05). In addition, total T and B lym-
phocyte percentages in haemodialysis-treated patients 
were lower than in those on peritoneal dialysis. 
T and B lymphocyte percentages observed in CKD 
patients and in the control group are shown in Figure 1, 
and haemoglobin and albumin concentrations observed 
in all three subgroups are displayed in Figure 2. Mean 
concentrations of haemoglobin and albumin were 
numerically lowered in all three subgroups of patients 
with CKD when compared to healthy controls. Figure 
3 shows T and B lymphocyte percentages according 
to the dialysis duration. 
Discussion
Immunological response mediated by lymphocytes 
is known to be impaired in CKD patients. The mecha-
nisms causing immunological deficiency in CKD have 
not been completely elucidated yet. The influence of 
dialysis on immune response has been intensively in-
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Figure 1. Comparison of T and B lymphocyte percentages
Table 2. Investigated parameters in three study subgroups and in the control group
Group Age (years) Total 
lymphocytes 
(%)
T 
lymphocytes 
(%)
B 
lymphocytes 
(%)
Haemoglobin 
[g/dL]
Albumin  
[g/dL]
Dialysis
duration 
(months)
Preemptive
(n = 42)
37 ± 14.7 53.3 ± 15.6 61.3 ± 22.0 1.8 ± 1.3 11.6 ± 1.6 3.9 ± 0.5 n/a
Haemodialysis
(n = 45)
35.5 ± 11.3 42.1 ± 16.0 55.6 ± 24.3 1.3 ± 0.8 12.2 ± 1.8 4.2 ± 0.5 27.2 ± 41.4
Peritoneal dialysis
(n = 16)
31.5 ± 11.6 52.8 ± 12.9 57.7 ± 24.2 1.6 ± 1.5 11.0 ± 1.9 3.2 ± 0.5 11.9 ± 22.5
Controls
(n = 103)
46.2 ± 12.4 54.7 ± 13.8 72.0 ± 14.1 2.5 ± 1.7 13.6 ± 1.8 4.4 ± 0.5 n/a
n/a — not applicable
Figure 2. Comparison of haemoglobin and albumin concentrations
vestigated and discussed with inconclusive results. The 
majority of studies showed that numbers of CD3+, 
CD4+, and CD8+ T lymphocytes and B lymphocytes 
were decreased in haemodialysis-treated patients 
[4–6]. In our study, CD3+ T lymphocytes and CD19+ 
B lymphocytes were numerically lower in patients on 
haemodialysis than in healthy donors. During dialysis, 
the bioincompatibility of dialyser membrane induces 
various negative changes in the peripheral blood. It was 
reported that these decreases in T and B lymphocyte 
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Figure 3. Changes in T and B lymphocyte percentages according to the dialysis duration
counts were consequences of the bioincompatibility 
of the dialyser membrane in the course of haemo-
dialysis or due to the side effects of uremic toxins in 
peripheral blood [7, 8]. Also, it has been known that 
T-lymphocyte subpopulations depend on a number of 
factors, including age, gender, stress, physical activity 
level, hormones, protein, and trace element uptake [9]. 
Erythropoietin production decreases in CKD patients, 
and this may affect lymphocyte count because erythro-
poietin receptor is expressed on T and B lymphocytes 
and monocytes. Treatment with erythropoietin of CKD 
patients improves cytokine production and costimula-
tory molecule expression [8]. Thus, it can potentially 
restore the lymphocyte function. Unfortunately, we were 
not aware which of our study participants were treated 
with erythropoietin.
Anaemia, hypoalbuminaemia, and malnutrition 
cause significant impairment of immune response in the 
setting of advanced CKD [10]. In this study, concentra-
tions of haemoglobin and albumin in CKD patients were 
numerically lower than in the control group. 
We observed that percentages of total lympho-
cytes as well as T and B lymphocytes in CKD patients 
decreased when they started therapy with dialysis. In 
the second year of the therapy (13th to 24th month), 
an increase in T and B lymphocyte levels was seen. In 
the following months of dialysis therapy, T lymphocyte 
counts decreased. B lymphocyte counts increased 
to the normal range after 52 months. Similar results 
were obtained by Grzegorzewska et al., who found 
a negative correlation between B lymphocyte count 
and dialysis duration [11]. Several studies indicated 
increased T lymphocyte apoptosis in CKD patients. In 
addition, decreased expression of apoptotic reg-
ulatory molecule Bcl-2 was demonstrated in CKD 
patients [8, 12].
Limitations of this study include: small sample size, 
case-control design without investigation of clinical end-
points, and the lack of evaluation of underlying mech-
anisms.
Conclusions
This study suggests that patients with advanced 
CKD have lower rates of lymphocytes that healthy 
controls. This fact may at least partially explain the 
impaired immunity in the CKD setting. However, our 
findings require confirmation and detailed investigation 
of underlying mechanisms in further studies.
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